Suppr超能文献

致敏的胸腺来源淋巴细胞诱发致命性淋巴细胞性脉络丛脑膜炎的能力受H-2基因复合体的限制。

Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.

作者信息

Doherty P C, Zinernagel R M

出版信息

J Immunol. 1975 Jan;114(1 Pt 1):30-3.

PMID:1078677
Abstract

Adoptive immunization of syngeneic, immunosuppressed recipients infected with lymphocytic choriomeningitis (LCM) virus causes fatal neurologic disease within 2 to 4 days of cell transfer, providing that donors are sampled when the in vitro 51-Cr release assay shows maximal specific activity of sensitized thymus-derived lymphocytes (T cells). Prior treatment of immune spleen cells with AKR anti-omicron ascitic fluid and complement causes total abrogation of this in vivo activity. Fatal neurologic disease is induced only when donor and recipient share at least one set of H-2 antigenic specificities. Parent yields F1 and F1 yields parent combinations are as effective as syngeneic systems, but mice given allogeneic immune cells survive as long as controlsmdifferences at the M-locus in H-2 compatible mice do not inhibit effector activity. Homing of transferred lymphocytes to spleen is similar in syngeneic or allogeneic recipients, but only syngeneic immune cells cross the blood-cerebrospinal fluid (CSF) barrier and cause choriomeningitis. Fatal LCM, is, therefore, apparently induced by a specifically sensitized omicron-bearing cell population, activity of which is restricted by the H-2 gene complex.

摘要

对感染淋巴细胞性脉络丛脑膜炎(LCM)病毒的同基因免疫抑制受体进行过继免疫,若在体外51 -铬释放试验显示致敏胸腺来源淋巴细胞(T细胞)具有最大比活性时采集供体样本,则在细胞转移后2至4天内会引发致命的神经系统疾病。用AKR抗奥米克戎腹水和补体对免疫脾细胞进行预处理会完全消除这种体内活性。仅当供体和受体至少共享一组H - 2抗原特异性时才会诱发致命的神经系统疾病。亲代产生F1以及F1产生亲代的组合与同基因系统一样有效,但给予异基因免疫细胞的小鼠存活时间与对照组相同——H - 2兼容小鼠中M位点的差异不会抑制效应活性。在同基因或异基因受体中,转移的淋巴细胞归巢至脾脏的情况相似,但只有同基因免疫细胞能穿过血脑脊髓液(CSF)屏障并引发脉络丛脑膜炎。因此,致命的LCM显然是由携带奥米克戎的特异性致敏细胞群体诱发的,其活性受H - 2基因复合体限制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验